2020
DOI: 10.1016/j.jcrc.2019.11.013
|View full text |Cite
|
Sign up to set email alerts
|

The clinical effect of hemostatic resuscitation in traumatic hemorrhage; a before-after study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
13
0
3

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(16 citation statements)
references
References 30 publications
0
13
0
3
Order By: Relevance
“…The results of the search and respective levels of screening are outlined in the PRISMA flowchart in Figure 1 [17]. Of those 47 articles, there were only 15, comprising of 2,715 patients, which had published data that could be used to quantitatively assess our primary outcome [18][19][20][21][22][23][24][25][26][27][28][29][30][31][32]. There was one RCT identified and remaining manuscripts were either retrospective or prospective observational studies of moderate methodological quality.…”
Section: Resultsmentioning
confidence: 99%
“…The results of the search and respective levels of screening are outlined in the PRISMA flowchart in Figure 1 [17]. Of those 47 articles, there were only 15, comprising of 2,715 patients, which had published data that could be used to quantitatively assess our primary outcome [18][19][20][21][22][23][24][25][26][27][28][29][30][31][32]. There was one RCT identified and remaining manuscripts were either retrospective or prospective observational studies of moderate methodological quality.…”
Section: Resultsmentioning
confidence: 99%
“…Já numa coorte que avaliou 405 pacientes com sangramento agudo, no grupo tratado com CCP e PFC, os pacientes que receberam doses mais altas de CCP (≥20 UI/kg) tiveram a maior utilização de hemoderivados, os autores apontaram para o possível risco de viés de seleção, uma vez que estes pacientes possuíam sangramento mais grave, e nesse mesmo estudo as plaquetas foram as mais comumente administradas após o paciente ter recebido CCP/PFC, seguido do concentrado de hemácias (Chowdary et al, 2018). Zwinkels et al (2020), mostraram redução na transfusão de concentrado de PFC e aumento do uso de concentrados de plaquetas e de fibrinogênio ao comparar pacientes que corrigiram a coagulopatia traumática através de um protocolo de ressuscitação hemostática, que incluía administração de hemoderivados e concentrados de fatores da coagulação (CF e CCP),…”
Section: Efeitos Na Redução Do Uso De Hemoderivadosunclassified
“…Excessive blood loss in trauma or surgery is one of the most common factors threatening human life and health, and the uncontrollable bleeding is also a primary cause of traumatic death [1,2]. Therefore, an efficient and suitable hemostatic agent is urgently needed to provide more options and opportunities for prehospital emergency hemostasis.…”
Section: Introductionmentioning
confidence: 99%